Lower IL-10 levels in NC+ may be interpreted as a failure in anti-inflammatory processes associated with onset of pathologic AD, or alternatively balanced anti- and proinflammatory responses in asymptomatic AD (e.g., we previously showed complement activation to accompany the MCI+ to AD transition [18]). Here, IL10 is linked to Alzheimer disease.